In accordance with the order to change the pharmaceutical manufacturing product approval from the Food and Drug Safety Administration (Drug Management Team No. 12885, effective date 2006. 04. 263) Cardil tablet, Cardil tablet 1 mg, Cardil XL extended-release tablet 4 mg (doxazosin mesylate)The precautions for use have changed.


For further details, please refer to the ‘Product Introduction’ section and attached documents.